Bdr Lifesciences Private Ltd, based in India, is a pharmaceutical company.
One of their notable products is OLAPARIB, with a corresponding US DMF Number 42527.
Remarkably, this DMF maintains an Active status since its submission on September 27, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 17, 2025, and payment made on September 18, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II